Simplex Trading’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $480K | Buy |
2,100
+1,200
| +133% | +$269K | ﹤0.01% | 3314 |
|
|
2025
Q4 | $192K | Sell |
900
-1,400
| -61% | -$289K | ﹤0.01% | 4279 |
|
|
2025
Q3 | $457K | Buy |
2,300
+1,600
| +229% | +$298K | ﹤0.01% | 3937 |
|
|
2025
Q2 | $120K | Sell |
700
-10,800
| -94% | -$1.76M | ﹤0.01% | 5051 |
|
|
2025
Q1 | $1.79M | Sell |
11,500
-3,900
| -25% | -$557K | ﹤0.01% | 2144 |
|
|
2024
Q4 | $2.12M | Buy |
15,400
+2,100
| +16% | +$276K | ﹤0.01% | 2138 |
|
|
2024
Q3 | $1.99M | Buy |
13,300
+5,900
| +80% | +$797K | ﹤0.01% | 2282 |
|
|
2024
Q2 | $1.01M | Buy |
7,400
+6,800
| +1,133% | +$925K | ﹤0.01% | 2899 |
|
|
2024
Q1 | $90K | Sell |
600
-1,100
| -65% | -$157K | ﹤0.01% | 5692 |
|
|
2023
Q4 | $214K | Sell |
1,700
-1,700
| -50% | -$169K | ﹤0.01% | 4613 |
|
|
2023
Q3 | $318K | Sell |
3,400
-7,200
| -68% | -$674K | ﹤0.01% | 3875 |
|
|
2023
Q2 | $946K | Sell |
10,600
-1,900
| -15% | -$165K | ﹤0.01% | 2652 |
|
|
2023
Q1 | $1.34M | Buy |
12,500
+3,500
| +39% | +$400K | ﹤0.01% | 2318 |
|
|
2022
Q4 | $1.1M | Buy |
+9,000
| New | +$1.04M | ﹤0.01% | 2374 |
|
|
2022
Q3 | – | Sell |
-3,600
| Closed | -$334K | – | 9848 |
|
|
2022
Q2 | $334K | Sell |
3,600
-5,600
| -61% | -$528K | ﹤0.01% | 3960 |
|
|
2022
Q1 | $1.08M | Buy |
9,200
+8,100
| +736% | +$938K | ﹤0.01% | 2825 |
|
|
2021
Q4 | $147K | Sell |
1,100
-1,900
| -63% | -$283K | ﹤0.01% | 5629 |
|
|
2021
Q3 | $403K | Hold |
3,000
| – | – | ﹤0.01% | 4431 |
|
|
2021
Q2 | $394K | Buy |
3,000
+2,978
| +13,536% | +$397K | ﹤0.01% | 4531 |
|
|
2021
Q1 | $283K | Buy |
22
+21
| +2,100% | +$3.19K | ﹤0.01% | 4209 |
|
|
2020
Q4 | $16K | Sell |
1
-2
| -67% | -$331 | ﹤0.01% | 7105 |
|
|
2020
Q3 | $46K | Buy |
+3
| New | +$431 | ﹤0.01% | 5670 |
|
|
2020
Q2 | – | Sell |
-162
| Closed | -$1.82M | – | 7553 |
|
|
2020
Q1 | $1.82M | Buy |
162
+159
| +5,300% | +$20.7K | ﹤0.01% | 1351 |
|
|
2019
Q4 | $41K | Sell |
3
-25
| -89% | -$2.78K | ﹤0.01% | 5369 |
|
|
2019
Q3 | $269K | Sell |
28
-252
| -90% | -$28.1K | ﹤0.01% | 3268 |
|
|
2019
Q2 | $3.22M | Buy |
280
+32
| +13% | +$3.83K | 0.01% | 964 |
|
|
2019
Q1 | $2.92M | Buy |
248
+130
| +110% | +$11.4K | 0.01% | 1047 |
|
|
2018
Q4 | $739K | Buy |
118
+68
| +136% | +$4.27K | ﹤0.01% | 1893 |
|
|
2018
Q3 | $354K | Hold |
50
| – | – | ﹤0.01% | 2978 |
|
|
2018
Q2 | $332K | Buy |
+50
| New | +$3.29K | ﹤0.01% | 2900 |
|
Other funds holding ASND
RCM
ACA
Simplex Trading's ASND Position: Q1 2025 in Review
Simplex Trading sold out of Ascendis Pharma A/S (ASND) in Q1 2025, closing a stake of 6,288 shares — an estimated $898K sold.
Simplex Trading first reported a position in ASND in Q2 2018 and held it in 16 quarters. The position peaked at $939K in Q4 2018. 244 funds tracked by Wall St. Rank hold ASND as of Q1 2025.
- Simplex Trading reported no remaining Ascendis Pharma A/S position as of Q1 2025 after selling out during the quarter.
- Simplex Trading sold 6,288 Ascendis Pharma A/S shares in Q1 2025, an estimated $898K.
- Simplex Trading first reported a position in Ascendis Pharma A/S in Q2 2018 and held it in 16 quarters.
- Simplex Trading's Ascendis Pharma A/S position peaked at $939K in Q4 2018.
- 244 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2025.
Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.